Investing in global health

For more than a decade we’ve been investing in the expansion of global healthcare.

Our healthcare strategy

The Covid-19 pandemic highlighted the need for capital investment to expand access to affordable and quality healthcare both in developing and developed countries. We offer strategies that does just this.

Investments for change

As a healthcare investment leader, we leverage private equity, real asset investment and infrastructure expertise to build a platform capable of creating measurable impact, even while targeting above market-rate returns for investors.

One unified platform

AXA IM Alts has made significant investments in healthcare over the past decade. Our unified platform covering several asset classes allows us to better leverage our expertise and market insights in the diverse healthcare sector. 

Investments with impact

Access to quality, affordable healthcare remains a key issue in many developing nations. Our private equity Healthcare strategy aims to contribute to bridging this gap by delivering affordable products and services where they can have the greatest impact.

Investing at scale

To create real impact, we invest in healthcare solutions at scale. Our strategy builds a bridge between the innovations of high-income markets in developed countries, and the high-volume markets of developing economies.

Investing with a clear goal

Taking the UN’s Sustainable Development Goals as our framework, we identify investments that create real, measurable impact – at scale – on healthcare access and provision for communities who need it most.

Comprehensive expertise

Utilising established connections maintained throughout the global health sector, our healthcare teams have the experience, financial rigour and technical knowledge to identify investments that will make a difference.

Responsible investing

Focus on the social outcome

While demographic and economic changes are rapidly changing the needs for healthcare in middle income countries, Private capital can contribute to a more equal access to healthcare globally.
Discover more in this video with Zina Affas Besse, Deputy Head of Healthcare Private Equity at AXA IM Alts, Jonathan Dean, Head of Fund Management at AXA IM Alts.

Explore Impact Investing

Healthcare infrastructure

We offer a transversal approach to healthcare investing, with a portfolio that not only covers impact investing but also healthcare real assets and infrastructure.

Investing in high growth assets

In 2020 we acquired Kadans, a leading owner and operator of science parks and lab offices in Europe. Through this investment we were able to build immediate scale in a sector that offer essential healthcare solutions in key markets.

Investing in leaders

We acquired Amedes, a provider of medical diagnostics services in Germany, Belgium and Austria, in 2021. The investment gave us access to their 75+ laboratories and specialty medicine sites, supporting sectors ranging from fertility medicine to rheumatology and oncology.

Our strategy

Through our investments in healthcare infrastructure and real assets, we are able to offer investors access to a sector supported by structural tailwinds while benefitting from typical asset class benefits such as resilient cash flows and low market-cycle impact.

Measurable results

400,000 1
Amedes analyses per day
1,100 1
lives expected to be saved each year through Jada post-partum haemorrhage device (PE healthcare)
65 %1
of Kadans portfolio with a grade A ESG rating

Help us make an impact

Interested in joining us and investing in what matters? We’re always looking for likeminded new team members.

Join us

Risk Warning

No assurance can be given that our strategies will be successful. Investors can lose some or all of their capital invested.


    Companies or assets are shown for illustrative purposes only and should not be considered as advice or a recommendation for an investment strategy.

    This marketing communication does not constitute on the part of AXA Investment Managers a solicitation or investment, legal or tax advice. This material does not contain sufficient information to support an investment decision.
    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    ESG disclaimer

    The ESG data used in the investment process are based on ESG methodologies which rely in part on third party data, and in some cases are internally developed. They are subjective and may change over time. Despite several initiatives, the lack of harmonised definitions can make ESG criteria heterogeneous. As such, the different investment strategies that use ESG criteria and ESG reporting are difficult to compare with each other. Strategies that incorporate ESG criteria and those that incorporate sustainable development criteria may use ESG data that appear similar but which should be distinguished because their calculation method may be different.